Fernanda Silva-Da
Waver, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Harmonizing the collection of solicited adverse events in prophylactic vaccine clinical trials.
Journal: Expert review of vaccines
Published: September 26, 2023
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.
Journal: EClinicalMedicine
Published: April 11, 2023
A Model for Monitoring Spontaneously Reported Medication Errors Using the Adjuvanted Recombinant Zoster Vaccine as an Example.
Journal: Advances in pharmacological and pharmaceutical sciences
Published: September 06, 2022
Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions.
Journal: Vaccine
Published: June 07, 2022
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
Journal: The Lancet. Infectious diseases
Published: October 08, 2021
An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.
Journal: Drug safety
Published: August 31, 2021
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study.
Journal: The Lancet. Infectious diseases
Published: January 20, 2021
Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study.
Journal: EClinicalMedicine
Published: August 28, 2019
Meta-analysis of the risk of autoimmune thyroiditis, Guillain-Barré syndrome, and inflammatory bowel disease following vaccination with AS04-adjuvanted human papillomavirus 16/18 vaccine.
Journal: Pharmacoepidemiology and drug safety
Published: July 02, 2019
Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans.
Journal: Vaccine
Published: September 12, 2018
Safety of AS03-adjuvanted influenza vaccines: A review of the evidence.
Journal: Vaccine
Published: June 07, 2018
Last Updated: 09/26/2026